Pharmacokinetics of a topical application of moxidectin in bare-nosed wombats (Vombatus ursinus).
Vet Parasitol Reg Stud Reports
; 53: 101074, 2024 Aug.
Article
em En
| MEDLINE
| ID: mdl-39025544
ABSTRACT
Sarcoptic mange is a debilitating disease that affects bare-nosed wombats (Vombatus ursinus). One of the drugs currently used for treatment is moxidectin, as it has a relatively high efficacy against endo and ectoparasites and side effects are uncommon in domestic species, thus it is considered a relatively safe drug to use at the recommended doses. Developing further understanding of the pharmacokinetics of moxidectin will aid in developing treatment regimens for sarcoptic mange in wombats. Here we analyzed the pharmacokinetic parameters of using 100 ml of moxidectin (5 g/l) applied topically. We found that mean peak plasma concentration was 0.50 ng/ml and half-life was 8 days. Moxidectin was excreted in scats with the mean peak concentration of 2461.43 ng/g (on a dry matter basis). Our study has provided the pharmacokinetic parameters of a commonly used treatment for sarcoptic mange in wombats. There were no adverse side effects recorded in the wombats after applying moxidectin topically. This study replicated real-world conditions using topical application on free-living wombats. The relatively low plasma concentration suggests the drug is not accumulating in the blood stream and is excreted via scats.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Temas:
Geral
Base de dados:
MEDLINE
Assunto principal:
Escabiose
/
Administração Tópica
/
Macrolídeos
/
Marsupiais
Limite:
Animals
Idioma:
En
Revista:
Vet Parasitol Reg Stud Reports
Ano de publicação:
2024
Tipo de documento:
Article